Advertisement
Screener

SPECTRUM PHARMACEUTICALS INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net

SPECTRUM PHARMACEUTICALS INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net

SPECTRUM PHARMACEUTICALS INC reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net of -$389.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.

Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet · last filed 2019-02-28

  • SPECTRUM PHARMACEUTICALS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for fiscal 2018 was -$389.00K.
  • SPECTRUM PHARMACEUTICALS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for fiscal 2017 was -$744.00K.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net 12 month
2018-12-31-$389.00K
10-K · filed 2019-02-28
2017-12-31-$744.00K
10-K · filed 2018-03-07